NIA is delighted to welcome it's first Associate Member from the contract research organisation (CRO) community, critical actors in successful nanomaterials market access and uptake. Covance CPC Regulatory Consultancy is part of the global CRO company Covance, which is involved in facilitating novel medicines to market.
This adds an important element to the NIA community, enabling us to explore and develop the formal routes to market through professionalised services. CROs are a critical element of all commercially mature sectors, providing professional services to meet regulatory and other market access requirements. As we strive to meet the NIA mission of supporting commercial development of nanomaterials, expansion of CRO services to address nanomaterials (and nanoforms within REACH Amendments) is a critical part of building confidence in nanomaterials and reducing cost of development to market.
NIA looks forward to working with Covance CPC Regulatory Consultancy and will be presenting within their 'EU Chemicals Sympoisum' on March 10 in Brussels. Read more about Covance CPC Regulatory Consultancy HERE.
